참고문헌
- 한국형 조현병 약물치료 알고리듬 개정 실무위원회. 2019 한국형 조현병 약물치료 지침서, 대한정신약물학회, 대한조현병학회;2019. p.10.
- Nielsen J, Correll CU, Manu P, Kane JM. Termination of clozapine treatment due to medical reasons: when is it warranted and how can it be avoided? J Clin Psychiatry 2013;74:603- 613; quiz 613. https://doi.org/10.4088/JCP.12r08064
- Siskind D, Siskind V, Kisely S. Clozapine response rates among people with treatment-resistant schizophrenia: data from a systematic review and meta-analysis. Can J Psychiatry 2017;62:772-777. https://doi.org/10.1177/0706743717718167
- Lowe CM, Grube RRA, Scates AC. Characterization and clinical management of clozapine-induced fever. Ann Pharmacother 2007;41:1700-1704. https://doi.org/10.1345/aph.1K126
- Verdoux H, Quiles C, de Leon J. Clinical determinants of fever in clozapine users and implications for treatment management: a narrative review. Schizophr Res 2019;211:1-9. https://doi.org/10.1016/j.schres.2019.07.040
- Bachmann CJ, Aagaard L, Bernardo M, Brandt L, Cartabia M, Clavenna A, Coma Fuste A, Furu K, Garuoliene K, Hoffmann F, Hollingworth S, Huybrechts KF, Kalverdijk LJ, Kawakami K, Kieler H, Kinoshita T, Lopez SC, Machado-Alba JE, Machado-Duque ME, Mahesri M, Nishtala PS, Piovani D, Reutfors J, Saastamoinen LK, Sato I, SchuilingVeninga CCM, Shyu Y-C, Siskind D, Skurtveit S, Verdoux H, Wang L-J, Zara Yahni C, Zoega H, Taylor D. International trends in clozapine use: a study in 17 countries. Acta Psychiatr Scand 2017;136:37-51. https://doi.org/10.1111/acps.12742
- Chengappa KN, Vasile J, Levine J, Ulrich R, Baker R, Gopalani A, Schooler N. Clozapine: its impact on aggressive behavior among patients in a state psychiatric hospital. Schizophr Res 2002;53:1-6.
- Meltzer HY, Alphs L, Green AI, Altamura AC, Anand R, Bertoldi A, Bourgeois M, Chouinard G, Islam MZ, Kane J, Krishnan R, Lindenmayer JP, Potkin S. Clozapine treatment for suicidality in schizophrenia: International Suicide Prevention Trial (InterSePT). Arch Gen Psychiatry 2003;60:82-91. https://doi.org/10.1001/archpsyc.60.1.82
- Li XB, Tang YL, Wang CY, de Leon J. Clozapine for treatment-resistant bipolar disorder: a systematic review. Bipolar Disord 2015;17:235-247.
- Delgado A, Velosa J, Zhang J, Dursun SM, Kapczinski F, de Azevedo Cardoso T. Clozapine in bipolar disorder: a systematic review and meta-analysis. J Psychiatr Res 2020;125:21-27. https://doi.org/10.1016/j.jpsychires.2020.02.026
- Miller DD. Review and management of clozapine side effects. J Clin Psychiatry 2000;61 Suppl 8:14-17; discussion 18-19. https://doi.org/10.4088/JCP.v61n0713e
- 김용식, 안용민, 정성훈, 신영민. 클로자핀 임상사용의 실제: 클로자핀에 대한 89가지 궁금증, 2판; 서울대학교출판문화원;2013. p.10-23, 75-82, 92-94, 173-174.
- Ng CH, Chong SA, Lambert T, Fan A, Hackett LP, Mahendran R, Subramaniam M, Schweitzer I. An inter-ethnic comparison study of clozapine dosage, clinical response and plasma levels. Int Clin Psychopharmacol 2005;20:163-168. https://doi.org/10.1097/00004850-200505000-00007
- Haring C, Meise U, Humpel C, Saria A, Fleischhacker W, Hinterhuber H. Dose-related plasma levels of clozapine: in-fluence of smoking behaviour, sex and age. Psychopharmacology 1989;99:S38-S40. https://doi.org/10.1007/BF00442557
- Belvederi Murri M, Bugliani M, Calcagno P, Respino M, Serafini G, Innamorati M, Pompili M, Amore M. Secondgeneration antipsychotics and neuroleptic malignant syndrome: systematic review and case report analysis. Drugs R D 2015; 15:45-62. https://doi.org/10.1007/s40268-014-0078-0
- Stroup TS, Gray N. Management of common adverse effects of antipsychotic medications. World Psychiatry 2018;17:341-356. https://doi.org/10.1002/wps.20567
- Schulte PF. Risk of clozapine-associated agranulocytosis and mandatory white blood cell monitoring. Ann Pharmacother 2006;40:683-688. https://doi.org/10.1345/aph.1G396
- Gerson SL. G-CSF and the management of clozapine-induced agranulocytosis. J Clin Psychiatry 1994.
- Iqbal MM, Rahman A, Husain Z, Mahmud SZ, Ryan WG, Feldman JM. Clozapine: a clinical review of adverse effects and management. Ann Clin Psychiatry 2003;15:33-48. https://doi.org/10.1023/A:1023228626309
- Whiskey E, Taylor D. Restarting clozapine after neutropenia. CNS Drugs 2007;21:25-35. https://doi.org/10.2165/00023210-200721010-00003
- Spencer BW, Williams HR, Gee SH, Whiskey E, Rodrigues JP, Mijovic A, MacCabe JH. Granulocyte Colony Stimulating Factor (G-CSF) can allow treatment with clozapine in a patient with severe Benign Ethnic Neutropaenia (BEN): a case report. J Psychopharmacol 2012;26:1280-1282. https://doi.org/10.1177/0269881112450782
- Gurrera RJ, Gearin PF, Love J, Li KJ, Xu A, Donaghey FH, Gerace MR. Recognition and management of clozapine adverse effects: a systematic review and qualitative synthesis. Acta Psychiatr Scand 2022;145:423-441. https://doi.org/10.1111/acps.13406
- Manu P, Sarpal D, Muir O, Kane JM, Correll CU. When can patients with potentially life-threatening adverse effects be rechallenged with clozapine? A systematic review of the published literature. Schizophr Res 2012;134:180-186. https://doi.org/10.1016/j.schres.2011.10.014
- Rohde C, Polcwiartek C, Kragholm K, Ebdrup B, Siskind D, Nielsen J. Adverse cardiac events in out-patients initiating clozapine treatment: a nationwide register-based study. Acta Psychiatr Scand 2018;137:47-53. https://doi.org/10.1111/acps.12827
- Scheftner WA, Shulman RB. Treatment choice in neuroleptic malignant syndrome. Convuls Ther;1992.
- Kuo CJ, Yang SY, Liao YT, Chen WJ, Lee WC, Shau WY, Chang YT, Tsai SY, Chen CC. Second-generation antipsychotic medications and risk of pneumonia in schizophrenia. Schizophr Bull 2013;39:648-657. https://doi.org/10.1093/schbul/sbr202
- Cicala G, Barbieri MA, Spina E, de Leon J. A comprehensive review of swallowing difficulties and dysphagia associated with antipsychotics in adults. Expert Rev Clin Pharmacol 2019;12:219-234. https://doi.org/10.1080/17512433.2019.1577134
- Clark SR, Warren NS, Kim G, Jankowiak D, Schubert KO, Kisely S, Forrester T, Baune BT, Siskind DJ. Elevated clozapine levels associated with infection: a systematic review. Schizophr Res 2018;192:50-56. https://doi.org/10.1016/j.schres.2017.03.045
- Schmidinger S, Hofer A. Pulmonary embolism and aspiration pneumonia after reexposure to clozapine: pulmonary adverse effects of clozapine. J Clin Psychopharmacol 2014;34: 385-387. https://doi.org/10.1097/JCP.0000000000000124
- de Leon J, Diaz FJ. Serious respiratory infections can increase clozapine levels and contribute to side effects: a case report. Prog Neuropsychopharmacol Biol Psychiatry 2003;27: 1059-1063. https://doi.org/10.1016/S0278-5846(03)00148-9
- Ruan CJ, Zhen XY, Ge XL, Li WB, Jose de Leon M. Case report pneumonia can cause clozapine intoxication: a case report. Psychosomatics 2017;58.
- De Leon J, Ruan CJ, Verdoux H, Wang C. Clozapine is strongly associated with the risk of pneumonia and inflammation. Gen Psychiatr 2020;33.
- Ruan CJ, de Leon J. Thirty years of both ignorance and clinical experience suggest that clozapine intoxication during cooccurring infections and inflammation may have higher morbidity and mortality than is currently believed. Psychosomatics 2019;60:221-222. https://doi.org/10.1016/j.psym.2018.07.009
- Roge R, Moller BK, Andersen CR, Correll CU, Nielsen J. Immunomodulatory effects of clozapine and their clinical implications: what have we learned so far? Schizophr Res 2012; 140:204-213. https://doi.org/10.1016/j.schres.2012.06.020
- Jeong SH, Ahn YM, Koo YJ, Kang UG, Kim YS. The characteristics of clozapine-induced fever. Schizophr Res 2002;56: 191-193. https://doi.org/10.1016/S0920-9964(01)00262-6
- Burk BG, Ward AH, Clark B. A case report of acute hypothermia during initial inpatient clozapine titration with review of current literature on clozapine-induced temperature dysregulations. BMC Psychiatry 2020;20:1-8. https://doi.org/10.1186/s12888-019-2374-2
- Kohen I, Afzal N, Hussain S, Manu P. Increases in C-reactive protein may predict recurrence of clozapine-induced fever. Ann Pharmacother 2009;43:143-147. https://doi.org/10.1345/aph.1L467
- Buzina N, Eterovic M. Life-threatening lupus-like syndrome associated with clozapine. J Clin Psychopharmacol 2016;36: 532-534. https://doi.org/10.1097/JCP.0000000000000550
- Rami AF, Barkan D, Mevorach D, Leitersdorf E, Caraco Y. Clozapine-induced systemic lupus erythematosus. Ann Pharmacother 2006;40:983-985. https://doi.org/10.1345/aph.1G552
- Wickert WA, Campbell NR, Martin L. Acute severe adverse clozapine reaction resembling systemic lupus erythematosus. Postgrad Med J 1994;70:940-941. https://doi.org/10.1136/pgmj.70.830.940-a
- Wolf J, Sartorius A, Alm B, Henn FA. Clozapine-induced lupus erythematosus. J Clin Psychopharmacol 2004;24:236-238. https://doi.org/10.1097/01.jcp.0000117430.83724.f9
- Bellissima BL, Tingle MD, Cicovic A, Alawami M, Kenedi C. A systematic review of clozapine-induced myocarditis. Int J Cardiol 2018;259:122-129. https://doi.org/10.1016/j.ijcard.2017.12.102
- Knoph KN, Morgan III RJ, Palmer BA, Schak KM, Owen AC, Leloux MR, Patel M, Leung JG. Clozapine-induced cardiomyopathy and myocarditis monitoring: a systematic review. Schizophr Res 2018;199:17-30. https://doi.org/10.1016/j.schres.2018.03.006
- Ronaldson KJ, Taylor AJ, Fitzgerald PB, Topliss DJ, Elsik M, McNeil JJ. Diagnostic characteristics of clozapine-in-duced myocarditis identified by an analysis of 38 cases and 47 controls. J Clin Psychiatry 2010;71:4443.
- Ronaldson K, Fitzgerald P, McNeil J. Clozapine-induced myocarditis, a widely overlooked adverse reaction. Acta Psychiatr Scand 2015;132:231-240. https://doi.org/10.1111/acps.12416
- Raja M, Raja S. Clozapine safety, 40 years later. Curr Drug Saf 2014;9:163-195. https://doi.org/10.2174/1574886309666140428115040
- Ronaldson KJ, Fitzgerald PB, Taylor AJ, Topliss DJ, McNeil JJ. A new monitoring protocol for clozapine-induced myocarditis based on an analysis of 75 cases and 94 controls. Aust N Z J Psychiatry 2011;45:458-465. https://doi.org/10.3109/00048674.2011.572852
- Chopra N, de Leon J. Clozapine-induced myocarditis may be associated with rapid titration: a case report verified with autopsy. Int J Psychiatry Med 2016;51:104-115. https://doi.org/10.1177/0091217415621269
- Lally J, Al Kalbani H, Krivoy A, Murphy KC, Gaughran F, MacCabe JH. Hepatitis, interstitial nephritis, and pancreatitis in association with clozapine treatment: a systematic review of case series and reports. J Clin Psychopharmacol 2018;38: 520-527. https://doi.org/10.1097/JCP.0000000000000922
- Sarvaiya N, Lapitskaya Y, Dima L, Manu P. Clozapine-associated pulmonary embolism: a high-mortality, dose-independent and early-onset adverse effect. Am J Ther 2018;25: e434-e438. https://doi.org/10.1097/MJT.0000000000000806
- Poudyal R, Lohani S. Clozapine associated pulmonary embolism: systematic review. J Community Hosp Intern Med Perspect 2019;9:300-304. https://doi.org/10.1080/20009666.2019.1627848
- Paciullo CA. Evaluating the association between clozapine and venous thromboembolism. Am J Health Syst Pharm 2008; 65:1825-1829. https://doi.org/10.2146/ajhp070638